1.8476
price down icon2.24%   -0.0424
after-market 시간 외 거래: 1.85 0.0024 +0.13%
loading
전일 마감가:
$1.89
열려 있는:
$1.87
하루 거래량:
4,464
Relative Volume:
0.50
시가총액:
$28.62M
수익:
$22.06M
순이익/손실:
$-30.94M
주가수익비율:
-0.8248
EPS:
-2.24
순현금흐름:
$-26.70M
1주 성능:
-1.20%
1개월 성능:
-5.25%
6개월 성능:
-53.20%
1년 성능:
-52.18%
1일 변동 폭
Value
$1.82
$1.87
1주일 범위
Value
$1.7725
$1.92
52주 변동 폭
Value
$1.635
$7.67

Casi Pharmaceuticals Inc Stock (CASI) Company Profile

Name
명칭
Casi Pharmaceuticals Inc
Name
전화
-
Name
주소
-
Name
직원
233
Name
트위터
Name
다음 수익 날짜
2024-11-14
Name
최신 SEC 제출 서류
Name
CASI's Discussions on Twitter

CASI을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
CASI
Casi Pharmaceuticals Inc
1.8476 29.28M 22.06M -30.94M -26.70M -2.24
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.93 25.76B 3.81B -644.79M -669.77M -6.24
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
445.43 114.53B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
AKTX
Akari Therapeutics Plc Adr
1.415 40.54M 0 0 0 0.00
Biotechnology icon
VRNA
Verona Pharma Plc Adr
84.10 6.44B 0 -153.72M -103.81M -2.00
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
490.81 65.13B 14.09B 4.50B 2.96B 39.28

Casi Pharmaceuticals Inc Stock (CASI) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2021-05-18 개시 BTIG Research Buy
2021-04-26 개시 Mizuho Buy
2020-10-23 개시 Oppenheimer Outperform
2016-09-22 개시 Maxim Group Buy
2015-10-29 재개 H.C. Wainwright Buy
2015-06-23 개시 H.C. Wainwright Buy
모두보기

Casi Pharmaceuticals Inc 주식(CASI)의 최신 뉴스

pulisher
May 22, 2025

CASI Pharmaceuticals (NASDAQ:CASI) Coverage Initiated by Analysts at StockNews.com - Defense World

May 22, 2025
pulisher
May 22, 2025

HC Wainwright Has Positive Forecast for CASI Q2 Earnings - Defense World

May 22, 2025
pulisher
May 21, 2025

Transcript : CASI Pharmaceuticals, Inc.Special Call - marketscreener.com

May 21, 2025
pulisher
May 21, 2025

CASI to Host Business and Clinical Update Conference Call | CASI Stock News - GuruFocus

May 21, 2025
pulisher
May 20, 2025

CASI Pharmaceuticals Schedules Business Update Amid Legal Proceedings - TipRanks

May 20, 2025
pulisher
May 20, 2025

CASI Pharmaceuticals (NASDAQ:CASI) Given “Buy” Rating at HC Wainwright - Defense World

May 20, 2025
pulisher
May 19, 2025

CASI Pharmaceuticals: HC Wainwright & Co. Reiterates Buy Rating - GuruFocus

May 19, 2025
pulisher
May 19, 2025

CASI Pharmaceuticals Provides Business and Clinical Update - ACCESS Newswire

May 19, 2025
pulisher
May 19, 2025

CASI Pharmaceuticals Schedules Major Business and Clinical Pipeline Review: What Investors Should Watch - Stock Titan

May 19, 2025
pulisher
May 16, 2025

Kaixin Pharmaceuticals Inc. entered into a definitive Equity and Assets Transfer Agreement to acquire Two subsidiaries in China from CASI Pharmaceuticals, Inc. for $20 million. - marketscreener.com

May 16, 2025
pulisher
May 16, 2025

CASI Pharmaceuticals Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 16, 2025
pulisher
May 16, 2025

CASI Pharmaceuticals Reports Q1 2025 Results and Asset Divestiture in China - TipRanks

May 16, 2025
pulisher
May 16, 2025

CASI Pharmaceuticals Sees Revenue Boost in Q1 and Advances Key Program | CASI Stock News - GuruFocus

May 16, 2025
pulisher
May 16, 2025

CASI Pharmaceuticals Announces First Quarter 2025 Business and Financial Results - ACCESS Newswire

May 16, 2025
pulisher
May 16, 2025

CASI Pharmaceuticals Exits China in $20M Deal While Posting Record 82% Revenue Growth - Stock Titan

May 16, 2025
pulisher
May 14, 2025

CASI Pharmaceuticals appoints new CFO - Investing.com

May 14, 2025
pulisher
May 14, 2025

CASI Pharmaceuticals appoints new CFO By Investing.com - Investing.com India

May 14, 2025
pulisher
May 14, 2025

CASI Pharmaceuticals Announces CFO Transition - TipRanks

May 14, 2025
pulisher
May 14, 2025

CASI Pharmaceuticals Inc Daniel Lang To Step Down From His Role As Co'S Chief Financial Officer - marketscreener.com

May 14, 2025
pulisher
May 14, 2025

CASI Pharmaceuticals (NASDAQ:CASI) Earns Hold Rating from Analysts at StockNews.com - Defense World

May 14, 2025
pulisher
May 12, 2025

CASI Pharmaceuticals divests equity in Chinese subsidiaries By Investing.com - Investing.com Canada

May 12, 2025
pulisher
May 12, 2025

CASI Pharmaceuticals Enters Into Definitive Agreement To Divest Assets in China - citybiz

May 12, 2025
pulisher
May 12, 2025

CASI to Divest Two Subsidiaries in China - marketscreener.com

May 12, 2025
pulisher
May 12, 2025

CASI Pharmaceuticals (CASI) Sells Equity and Rights to Kaixin Ph - GuruFocus

May 12, 2025
pulisher
May 12, 2025

CASI Pharmaceuticals Divests Chinese Assets in $20 Million Deal - TipRanks

May 12, 2025
pulisher
May 12, 2025

CASI Pharmaceuticals divests equity in Chinese subsidiaries - Investing.com

May 12, 2025
pulisher
May 12, 2025

CASI Pharmaceuticals Enters Into Definitive Agreement for the Divestiture of Assets in China - ACCESS Newswire

May 12, 2025
pulisher
May 11, 2025

CASI Pharmaceuticals (CASI) to Release Earnings on Tuesday - Defense World

May 11, 2025
pulisher
May 08, 2025

CASI Pharmaceuticals faces Nasdaq delisting over market value By Investing.com - Investing.com Nigeria

May 08, 2025
pulisher
May 07, 2025

CASI Pharmaceuticals Faces Nasdaq Listing Compliance Challenge | CASI Stock News - GuruFocus

May 07, 2025
pulisher
May 07, 2025

CASI Pharmaceuticals Faces Nasdaq Compliance Challenge - TipRanks

May 07, 2025
pulisher
May 07, 2025

Casi Pharmaceuticals receives Nasdaq deficiency notice - TipRanks

May 07, 2025
pulisher
May 07, 2025

CASI Pharmaceuticals faces Nasdaq delisting over market value - Investing.com Australia

May 07, 2025
pulisher
May 07, 2025

CASI Pharmaceuticals Receives Nasdaq Deficiency Notice Regarding Minimum Market Value Requirement - ACCESS Newswire

May 07, 2025
pulisher
May 06, 2025

StockNews.com Begins Coverage on CASI Pharmaceuticals (NASDAQ:CASI) - Defense World

May 06, 2025
pulisher
May 02, 2025

CASI Announces First Patient Dosed in Phase 1/2 Clinical Trial of CID-103 in Immune Thrombocytopenia - ACCESS Newswire

May 02, 2025
pulisher
Apr 17, 2025

CASI Pharmaceuticals, Inc.Ordinary Shares (NQ: CASI - FinancialContent

Apr 17, 2025
pulisher
Apr 12, 2025

Brokers Issue Forecasts for CASI Q1 Earnings - Defense World

Apr 12, 2025
pulisher
Apr 12, 2025

StockNews.com Initiates Coverage on CASI Pharmaceuticals (NASDAQ:CASI) - Defense World

Apr 12, 2025
pulisher
Apr 11, 2025

HC Wainwright Has Lowered Expectations for CASI Pharmaceuticals (NASDAQ:CASI) Stock Price - Defense World

Apr 11, 2025
pulisher
Apr 10, 2025

CASI stock touches 52-week low at $1.88 amid market challenges - Investing.com

Apr 10, 2025
pulisher
Apr 09, 2025

CASI Pharmaceuticals Moves to Arbitration in Dispute with Acrotech - TipRanks

Apr 09, 2025
pulisher
Apr 07, 2025

CASI receives updated buyout offer for China operations - The Pharma Letter

Apr 07, 2025
pulisher
Apr 05, 2025

CASI Pharma Stock Rises On $20M Buyout Offer From CEO For China Business Operations: Retail Remains Extremely - Asianet Newsable

Apr 05, 2025
pulisher
Apr 03, 2025

CASI Pharma stock hits 52-week low at $1.9 amid market challenges - Investing.com Australia

Apr 03, 2025
pulisher
Apr 03, 2025

CASI Pharma Stock Rises On $20M Buyout Offer From CEO For China Business Operations: Retail Remains Extremely Bullish - MSN

Apr 03, 2025
pulisher
Apr 03, 2025

CASI Pharmaceuticals receives buyout proposal from CEO By Investing.com - Investing.com South Africa

Apr 03, 2025

Casi Pharmaceuticals Inc (CASI) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$1.15
price up icon 6.48%
$31.19
price up icon 3.48%
$584.61
price up icon 1.98%
$306.09
price up icon 0.50%
$4.5994
price up icon 2.21%
$490.81
price up icon 0.11%
자본화:     |  볼륨(24시간):